Can a hypnosis app help kids with ADHD focus and feel less anxious?
NCT ID NCT05741307
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether a self-hypnosis smartphone app called Hypnotidoo could improve attention and reduce anxiety in children aged 7 to 12 with ADHD who were already taking methylphenidate. The app offers short, screenless audio sessions with stories and breathing exercises. Researchers measured changes using parent and child questionnaires over 14 weeks. The goal was to see if adding the app to standard treatment provides extra benefit.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
self-hypnosis smartphone application (Hypnotidoo)
What this could lead to
If it works, this could offer a simple, non-drug tool to help children with ADHD manage inattention and anxiety alongside their usual medication.
What could go wrong
This is a small, early-stage study with only 49 participants and no blinding, so results may not be reliable or apply to all children with ADHD.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTENTION-DEFICIT / HYPERACTIVITY DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Necker-Enfants Malades
Paris, 75015, France